These are the clinical trials that led to the FDA’s approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.
Mehdi Jorfi, PhD, discusses the opportunities to optimize the development and application of neurotechnologies for AD.
Findings published in 2020 suggest that irregular sleep schedules may increase CVD risk independent of sleep quality or duration.
Danny Eckert, PhD, a researcher on human sleep and respiratory physiology, explains the potential bidirectional relationship and the clinical complications of COMISA, comorbid insomnia and sleep apnea.
Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in ADRD and how to improve clinical outcomes for patients from underrepresented groups.
Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.
Joseph D. Dougherty, PhD discusses genetic compounds’ ability to clear amyloid-β from the brain in patients with Alzheimer disease.
Sameed Khatana MD, and Barrak Alahmad, MD, discuss the impact of climate change on patients’ risk for cardiovascular disease.
Christa O’Hana S. Nobleza, MD, MSCI, a board certified physician who specializes in neurocritical care, highlights the importance of addressing mental health needs and finding solutions for physicians.